People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ten Bay Bio, Inc. | — | Biotech / Pharma | Series A | $11.5M | $58.5M | 2024 |
Andrew Kadlec at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew Kadlec on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Casey Cunningham | 1 | 7 |
| Paul Weiss | 1 | 5 |
| Tim Mayleben | 1 | 4 |
| Omar Khalil | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.